DE69723393D1 - Substituierte tricyclische Verbindungen - Google Patents

Substituierte tricyclische Verbindungen

Info

Publication number
DE69723393D1
DE69723393D1 DE69723393T DE69723393T DE69723393D1 DE 69723393 D1 DE69723393 D1 DE 69723393D1 DE 69723393 T DE69723393 T DE 69723393T DE 69723393 T DE69723393 T DE 69723393T DE 69723393 D1 DE69723393 D1 DE 69723393D1
Authority
DE
Germany
Prior art keywords
tricyclic compounds
substituted tricyclic
substituted
compounds
tricyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69723393T
Other languages
English (en)
Other versions
DE69723393T2 (de
Inventor
Nicholas James Bach
Robert Delane Dillard
Susan Elizabeth Draheim
Morin, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69723393D1 publication Critical patent/DE69723393D1/de
Application granted granted Critical
Publication of DE69723393T2 publication Critical patent/DE69723393T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pyridine Compounds (AREA)
DE69723393T 1996-10-30 1997-10-29 Substituierte tricyclische Verbindungen Expired - Lifetime DE69723393T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2984996P 1996-10-30 1996-10-30
US29849P 1996-10-30

Publications (2)

Publication Number Publication Date
DE69723393D1 true DE69723393D1 (de) 2003-08-14
DE69723393T2 DE69723393T2 (de) 2004-06-09

Family

ID=21851210

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69723393T Expired - Lifetime DE69723393T2 (de) 1996-10-30 1997-10-29 Substituierte tricyclische Verbindungen

Country Status (26)

Country Link
EP (1) EP0839806B1 (de)
JP (1) JP2001503055A (de)
KR (1) KR20000049210A (de)
CN (1) CN1233176A (de)
AR (1) AR010050A1 (de)
AT (1) ATE244703T1 (de)
AU (1) AU734096B2 (de)
BR (1) BR9713261A (de)
CA (1) CA2269203A1 (de)
CO (1) CO4920250A1 (de)
CZ (1) CZ136899A3 (de)
DE (1) DE69723393T2 (de)
DK (1) DK0839806T3 (de)
EA (1) EA003992B1 (de)
ES (1) ES2202560T3 (de)
ID (1) ID18685A (de)
IL (1) IL129481A0 (de)
NO (1) NO314899B1 (de)
NZ (1) NZ335246A (de)
PE (1) PE10999A1 (de)
PL (1) PL332896A1 (de)
PT (1) PT839806E (de)
TR (1) TR199900956T2 (de)
TW (1) TW513428B (de)
WO (1) WO1998018464A1 (de)
YU (1) YU19299A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1011670A4 (de) * 1997-08-28 2004-10-27 Lilly Co Eli Verfahren zur behandlung von nicht-rheumatischer arthritis
KR20010042307A (ko) 1998-03-31 2001-05-25 시오노 요시히코 피롤로[1,2-a]피라진 sPLA2 억제제
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
IL129484A0 (en) * 1998-04-17 2000-02-29 Lilly Co Eli Substituted tricyclics
WO1999057100A1 (en) 1998-05-01 1999-11-11 Eli Lilly And Company Spla2 inhibitor compounds for treatment of disease
JP4544446B2 (ja) 1998-05-21 2010-09-15 塩野義製薬株式会社 sPLA2阻害作用を有するピロロ[1,2−b]ピリダジン誘導体
DE69931963D1 (de) 1998-10-14 2006-07-27 Shionogi & Co Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
DE69910432D1 (de) * 1998-12-22 2003-09-18 Lilly Co Eli Substituierte pyrroloindole
WO2001005789A1 (fr) 1999-07-19 2001-01-25 Shionogi & Co., Ltd. Composes tricycliques a action inhibitrice a l'encontre de spla¿2?
AU6023200A (en) 1999-08-02 2001-02-19 Shionogi & Co., Ltd. Tricyclic compounds having spla2-inhibitory activities
WO2001014378A1 (fr) 1999-08-23 2001-03-01 Shionogi & Co., Ltd. DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2?
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
US6756376B1 (en) 1999-11-15 2004-06-29 Shionogi & Co., Ltd. Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities
JP2003519198A (ja) * 2000-01-06 2003-06-17 イーライ・リリー・アンド・カンパニー 炎症性疾患および呼吸器疾患の処置のための併用療法
US6967200B2 (en) 2000-06-29 2005-11-22 Shionogi & Co., Ltd. Remedies for cirrhosis
WO2002000621A1 (fr) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Composes inhibiteurs de la spla2 de type x
WO2002050034A2 (en) * 2000-12-18 2002-06-27 Eli Lilly And Company Tetracyclic carbazole derivates and their use as spla2 inhibitors
TWI314457B (de) * 2001-03-19 2009-09-11 Shionogi & Co
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
CN101048402B (zh) 2004-10-29 2011-11-09 泽里新药工业株式会社 咔唑衍生物、其溶剂合物或其药学上允许的盐
ES2924728T3 (es) 2015-06-15 2022-10-10 Raziel Therapeutics Ltd Derivados de carbazol para el tratamiento de enfermedades fibróticas, así como de síntomas y afecciones relacionados con las mismas
CN112409493B (zh) * 2020-08-12 2022-09-30 浙江工业大学 一种重组融合酶及其在乙醛酸甲酯合成中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479391A (en) * 1966-10-03 1969-11-18 Squibb & Sons Inc Delta**3,14-17alpha-hydroxy-norprogesterone and esters
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0839806A1 (de) 1998-05-06
TR199900956T2 (xx) 1999-07-21
CA2269203A1 (en) 1998-05-07
EA003992B1 (ru) 2003-12-25
KR20000049210A (ko) 2000-07-25
CN1233176A (zh) 1999-10-27
AU734096B2 (en) 2001-06-07
DE69723393T2 (de) 2004-06-09
AR010050A1 (es) 2000-05-17
DK0839806T3 (da) 2003-10-27
TW513428B (en) 2002-12-11
NO314899B1 (no) 2003-06-10
PL332896A1 (en) 1999-10-25
WO1998018464A1 (en) 1998-05-07
BR9713261A (pt) 2000-03-28
JP2001503055A (ja) 2001-03-06
YU19299A (sh) 2000-03-21
ES2202560T3 (es) 2004-04-01
NZ335246A (en) 2001-09-28
EP0839806B1 (de) 2003-07-09
CZ136899A3 (cs) 1999-09-15
NO991831D0 (no) 1999-04-16
IL129481A0 (en) 2000-02-29
ATE244703T1 (de) 2003-07-15
PT839806E (pt) 2003-11-28
NO991831L (no) 1999-06-21
CO4920250A1 (es) 2000-05-29
PE10999A1 (es) 1999-02-10
ID18685A (id) 1998-04-30
EA199900305A1 (ru) 1999-12-29
AU5149498A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
ATE298739T1 (de) Calcylitische verbindungen
DE69707189T2 (de) Östrogene Verbindungen
ATE208377T1 (de) Substituierte benzylaminopiperloin verbindungen
ATE244703T1 (de) Substituierte tricyclische verbindungen
ID19403A (id) Senyawa-senyawa heterosiklik
ID19609A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
NO991821D0 (no) Substituerte tricykliske forbindelser
BR9710352A (pt) Compostos piridilpirrole
ATE222893T1 (de) Triazinylaminostilben verbindungen
DE69716924T2 (de) Phosphonat-nukleotid-verbindungen
LV12207A (lv) Tricikliski savienojumi
BR9705635A (pt) Compostos
NO991823D0 (no) Substituerte tricykliske forbindelser
ATE225364T1 (de) Bromotiacumicin verbindungen
DE69801556T2 (de) Spirocyclische Verbindungen
DE59803962D1 (de) Polycyclische Verbindungen
DE69709659T2 (de) Halopropargyl-einschlussverbindungen
DE69702739T2 (de) Farbbildende verbindungen
DE69719054T2 (de) Trizyclische carbapenem-verbindungen
SE9604154D0 (sv) Anticancer compounds
SE9600275D0 (sv) Compounds
ID17103A (id) Senyawa-senyawa sulfonamida

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN